We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Outcomes of a Trial of HIV-1 Immunogen in Patients With HIV Infection

Donald M. Poretz, MD
JAMA. 2001;285(17):2191-2195. doi:10.1001/jama.285.17.2191.
Text Size: A A A
Published online


To the Editor: I was an investigator in the recently published HIV-1 Immunogen protocol.1 I was therefore surprised to see the results published without having had at least an opportunity to review the manuscript. The authors generically included the term 806 Investigator Team even though most of the participating investigators did not have any input into the article. In my experience, investigators who are involved in interinstitutional studies usually have the ability to offer comments and make suggestions before an article is submitted for publication. In this case, it appears that a roadblock was reached between the lead authors and the sponsoring company. According to the sponsor, the IRC, the authors refused to incorporate a cohort of patients that the company thought was of scientific merit (Ronald Moss, MD, vice president of Medical and Scientific Affairs, IRC, written communication, October 30, 2000). Arguments can be made for both sides in this debate and it is most unfortunate that a satisfactory conclusion was not obtained. Reviewers of the manuscript could have determined whether the added data were valuable enough to be included in the final publication. Additionally, I wonder why the authors did not request a complete listing of individual investigators and institutions involved in the trial. This information was obtainable from the sponsor.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.